Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
DePuy Hip Recall and Litigation Expenses Hit Johnson & Johnson Profits July 21, 2011 Staff Writers Add Your CommentsJohnson & Johnson has reported to shareholders that the costs associated with litigation and recalls involving its DePuy Orthopaedics unit significantly cut into profits in the second quarter of 2011.ย In its second-quarter earnings results, Johnson & Johnson reported that it paid $223 million in connection with DePuy ASR hip replacement recalls, litigation associated with the defective hip implant and other products. The company reported a net income of $2.8 billion, down from $3.5 billion a year ago.It has been nearly a year since Johnson & Johnson’s DePuy subsidiary recalled ASR hip implants last August, and more than 1,000 people have already filed a DePuy ASR hip lawsuit against the company over problems experienced when the implant failed.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONMore than 90,000 DePuy ASR XL Acetabular Systems and DePuy ASR Hip Resurfacing Systems were sold before the device was pulled from the market. At the time of the recall, the manufacturers acknowledged that an estimated 12% to 13% of these hips were failing within five years. However, more recent estimates have suggested that the DePuy ASR failure rate will be much higher. According to a report issued earlier this year, one group of surgeons indicated that half of all people who received the recalled implant may experience loosening within six years of their hip replacement, with many requiring additional surgery to remove or replace the components.According to allegations raised in complaints filed against Johnson & Johnson and their DePuy subsidiary, the manufacturer failed to adequately research the metal-on-metal hip implant or warn about the risk of problems caused by metallosis, or metal poisoning, which may occur when the metal parts rub against each other and shed microscopic particals of cobalt and chromium.Earlier this month, a Wells Fargo analyst estimated that Johnson & Johnson could face $1 billion in liability costs related to the DePuy ASR hip litigation.The company also faces a growing number of DePuy Pinnacle hip replacement lawsuits filed over another of their metal-on-metal hip implants. Although a DePuy Pinnnacle recall has not been issued, a dozens of complaints have been filed in courts throughout the United States alleging that the older hip system contains similar design defects that increase the risk of early loosening or failure. Tags: DePuy, DePuy ASR, DePuy Hip Replacement, DePuy Pinnacle, Hip Replacement, Johnson & Johnson, Metal-on-Metal Hip, Metal-on-Metal Hip Replacement, Metallosis Image Credit: |More Lawsuit Stories Judge Appoints Spinal Cord Stimulator Lawyers to Leadership Roles in Boston Scientific MDL August 24, 2026 Kratom Addiction Lawsuit Alleges Opioid-Like Products Caused Addiction, Cardiac Injury August 24, 2026 Clear Eyes Recall Issued Due to Risk Eye Drops May Be Contaminated August 24, 2026 0 Comments NameThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Judge Appoints Spinal Cord Stimulator Lawyers to Leadership Roles in Boston Scientific MDL (Posted: today)A federal judge has appointed a group of plaintiffs attorneys to leadership positions in the growing Boston Scientific spinal cord stimulator federal litigation.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITBoston Scientific Stimulator Lawsuit Alleges Spine Implant Caused Nerve Damage, Shocks (08/18/2026)Nevro Stimulator Lawsuit MDL Request Opposed by Manufacturer (08/14/2026)Abbott Continues to Oppose Spinal Cord Stimulator Lawsuit MDL, Despite Mounting Claims (08/10/2026) Similac Settlement Provides $670M Payout To Resolve 2,000 NEC Lawsuits (Posted: 3 days ago)Abbott Laboratories has agreed to pay $670 million to resolve more than 2,000 Similac NEC injury lawsuits, as the first federal NEC trial against competitor Mead Johnson gets underway.MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITMissouri Appeals Court Orders New Trial for Similac, Enfamil NEC Lawsuit (08/20/2026)Enfamil Necrotizing Enterocolitis Lawsuit Set for Trial to Begin This Week (08/11/2026)Neocate Infant Formula Lawsuit Alleges Nutritional Defect Caused Rickets, Bone Fractures (08/05/2026) Dupixent Lymphoma Lawsuit Alleges Atopic Dermatitis Drug Led to Mycosis Fungoides Diagnosis (Posted: 4 days ago)A California woman’s Dupixent lymphoma lawsuit claims the manufacturers knew of the eczema drug’s cancer risks, but refused to inform doctors and patients.MORE ABOUT: DUPIXENT LAWSUITDupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges (08/11/2026)CTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use (07/29/2026)Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis (07/21/2026)
Judge Appoints Spinal Cord Stimulator Lawyers to Leadership Roles in Boston Scientific MDL August 24, 2026
Kratom Addiction Lawsuit Alleges Opioid-Like Products Caused Addiction, Cardiac Injury August 24, 2026
Judge Appoints Spinal Cord Stimulator Lawyers to Leadership Roles in Boston Scientific MDL (Posted: today)A federal judge has appointed a group of plaintiffs attorneys to leadership positions in the growing Boston Scientific spinal cord stimulator federal litigation.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITBoston Scientific Stimulator Lawsuit Alleges Spine Implant Caused Nerve Damage, Shocks (08/18/2026)Nevro Stimulator Lawsuit MDL Request Opposed by Manufacturer (08/14/2026)Abbott Continues to Oppose Spinal Cord Stimulator Lawsuit MDL, Despite Mounting Claims (08/10/2026)
Similac Settlement Provides $670M Payout To Resolve 2,000 NEC Lawsuits (Posted: 3 days ago)Abbott Laboratories has agreed to pay $670 million to resolve more than 2,000 Similac NEC injury lawsuits, as the first federal NEC trial against competitor Mead Johnson gets underway.MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITMissouri Appeals Court Orders New Trial for Similac, Enfamil NEC Lawsuit (08/20/2026)Enfamil Necrotizing Enterocolitis Lawsuit Set for Trial to Begin This Week (08/11/2026)Neocate Infant Formula Lawsuit Alleges Nutritional Defect Caused Rickets, Bone Fractures (08/05/2026)
Dupixent Lymphoma Lawsuit Alleges Atopic Dermatitis Drug Led to Mycosis Fungoides Diagnosis (Posted: 4 days ago)A California woman’s Dupixent lymphoma lawsuit claims the manufacturers knew of the eczema drug’s cancer risks, but refused to inform doctors and patients.MORE ABOUT: DUPIXENT LAWSUITDupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges (08/11/2026)CTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use (07/29/2026)Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis (07/21/2026)